Barnes-Jewish Hospital
Locations
Transplant Summary
Overview
Barnes-Jewish Hospital and St. Louis Children's Hospital are part of BJC Healthcare, one of the largest nonprofit health care organizations in the United States, and the Alvin J. Siteman Cancer Center is Missouri's only NCI-designated Comprehensive Cancer Center. Our program works closely with Washington University School of Medicine physicians and researchers, and we are committed to providing the highest quality care and to developing innovative treatments to improve patient survival and quality of life.This center has been performing allogeneic transplants since 1982 and has been an NMDP transplant center since April 1991.
Attending physicians
Adult - Camille Abboud, Ramzi Abboud, Kelly Bolton, Amanda Cashen, Matthew Christopher, Zachary Crees, Ryan Day, John Dipersio, Todd Fehniger, Francesca Ferraro, Armin Ghobadi, Meagan Jacoby, Brad Kahl, Miriam Kim, Michael Kramer, Karolyn Oetjen, Dilan Patel, Giulia Petrone, Iskra Pusic, Mark Schroeder, Nathan Singh, Michael Slade MD, Keith Stockerl-Goldstein, Stefan Tarnawsky, Samuel Urrutia Argueta, Geoffrey Uy, Ravi Vij, Matthew Walter
Pediatric - Mohamed Abdelbaki, Amy Armstrong, Jeffrey Bednarski, Nicole Brossier, Andrew Cluster, Jorge Di Paola, Margaret Ferris, Melanie Fields , Robert Hayashi, Mikey Huang, Fred Huang, Jeff Magee, Melissa Mavers, Thomas Pfeiffer, Surbhi Saini, Laura Schuettpelz, Angela Shaw, Shalini Shenoy, Brian Sisk, Daniel Willlis, David Wilson, Kristen ZornTransplants performed
Marrow/PBSC, single cord, and double cordCord blood transplants
Adult and pediatricOther programs and services
Siteman Counseling Service
Ronald McDonald House, Hope Lodge, Barnes-Lodge
discounts with local hotels and short-term lodging
Survivorship Program; Nutritional Counseling; free smoking cessation programPatient survival information for this center
Barnes Jewish Hospital
This center's actual 1-year survival results are below the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 339 patients.The actual 1-year survival of these patients is 64.8%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 66% and 75.1%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.Washington University/St Louis Children's Hospital
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 60 patients.The actual 1-year survival of these patients is 86.5%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 79.8% and 95.6%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
693
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow4PBSC146Cord blood0Total150Unrelated donorMarrow5PBSC136Cord blood0Total141Total allogeneicMarrow9PBSC282Cord blood0Total291AutologousMarrowBoth marrow & PBSC 402PBSC—Cord blood—Total402Total combinedMarrowBoth marrow & PBSC 693PBSC—Cord blood0Total693Total pediatric transplants
89
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow20PBSC9Cord blood0Total29Unrelated donorMarrow24PBSC8Cord blood0Total32Total allogeneicMarrow44PBSC17Cord blood0Total61AutologousMarrowBoth marrow & PBSC 28PBSC—Cord blood—Total28Total combinedMarrowBoth marrow & PBSC 89PBSC—Cord blood0Total89All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-182819-443545-647965+37Total179Unrelated 0-182919-444545-646665+33Total173Autologous 0-182719-445845-6416465+181Total430Total 0-188419-4413845-6430965+251Total782Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
Barnes-Jewish Hospital at Washington University School of Medicine
660 S Euclid Campus Box 8007 St Louis, MO 63110 Phone:314-454-8304 Physician Referrals:314-454-8339 For more information about this program: http://www.siteman.wustl.edu (Opens in a new tab)Overview
Patients are managed within the clinical team post transplant. They are not routed to a different provider for survivorship care. New strategies for survivorship program development are being researched currently. The program anticipates some improved education to be provided to the patients in a means to improve ultimate patient care. The NP Manager will be implementing a pilot on survivorship in 2019. All post allo patients will also receive survivorship care plans as part of their 1 yr milestone visit. Currently this has not been streamlined. All patients are followed by their primary BMT Provider as needed, including milestone visits at 1 month, 100 days, 6 months, and annually.
Staff
Program Director:Peter Westervelt, MDProgram Coordinator:Stephanie Larson, RN, MSN,Medical Specialties in Program
Cardiology, dermatology, endocrinology, gastroenterology, gynecology, infectious disease, ophthalmology/optometry, orthopedics, palliative care, psychiatry/psychology, pulmonology.Medical Services Offered
Chronic GVHD management, fertility counseling, reproductive health, financial counseling, nutrition/dietetics, pain management, sexual health, social services, vaccinations.Telemedicine services are available.Patient Eligibility
Adults- Allogeneic and Autologous transplant recipients
- Adults (over age 18)
- Will provide care to adult patients who underwent transplant as a child
- Does accept patients who were transplanted at another hospital